Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
Public ClinicalTrials.gov record NCT04530344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the duration of response following withdrawal of ruxolitinib cream (Cohort A vehicle group), safety and maintenance of response with continued use of ruxolitinib cream in participants who have completed either Study NCT04052425 or NCT04057573 (parent studies) in which the participants will have been using ruxolitinib cream BID for the previous 28 to 52 weeks depending on their initial randomization in the parent study.
Study identification
- NCT ID
- NCT04530344
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 458 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 24, 2020 (Actual)
- Primary completion
- Nov 14, 2022 (Actual)
- Completion
- Nov 14, 2022 (Actual)
- Last update posted
- Aug 14, 2025
2020 – 2022
United States locations
- U.S. sites
- 44
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology | Hoover | Alabama | 35244 | — |
| Desert Sky Dermatology | Gilbert | Arizona | 85295 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Center For Dermatology Cosmetic and Laser Surgery | Fremont | California | 94538 | — |
| Marvel Clinical Research Llc | Huntington Beach | California | 92647 | — |
| Vitiligo & Pigmentation Institute of Southern California | Los Angeles | California | 90036 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Acrc Studies | San Diego | California | 92119 | — |
| University of California San Francisco | San Francisco | California | 94158 | — |
| Colorado Medical Research Center Inc | Denver | Colorado | 80210 | — |
| Harmony Medical Research Institute | Hialeah | Florida | 33016 | — |
| Advanced Pharma | Miami | Florida | 33147 | — |
| San Marcus Research Clinic Inc. | Miami Lakes | Florida | 33014 | — |
| Leavitt Medical Associates of Florida | Ormond Beach | Florida | 32174 | — |
| Avita Clinical Research | Tampa | Florida | 33613 | — |
| Olympian Clinical Research | Tampa | Florida | 33614 | — |
| Forcare Clinical Research Fcr Forward Clinical Trials, Inc | Tampa | Florida | 33624 | — |
| Metabolic Research Institute Inc | West Palm Beach | Florida | 33401 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Randall Dermatology | West Lafayette | Indiana | 47906 | — |
| Delricht Clinical Research - Clinedge - Ppds Baton Rouge | Baton Rouge | Louisiana | 70809 | — |
| Tufts Medical Center | Boston | Massachusetts | 02116 | — |
| Metro Boston Clinical Partners | Brighton | Massachusetts | 02135 | — |
| Great Lakes Research Group Inc | Bay City | Michigan | 48706 | — |
| Henry Ford Medical Center | Detroit | Michigan | 48202 | — |
| Minnesota Clinical Study Center | Minneapolis | Minnesota | 55432 | — |
| Jdr Dermatology Research | Las Vegas | Nevada | 89148 | — |
| Suny Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Forest Hills Dermatology Group | Kew Gardens | New York | 11415 | — |
| The Dermatology Specialists Greenwich | New York | New York | 10012 | — |
| Icahn School of Medicine At Mount Sinai | New York | New York | 10029 | — |
| Derm Research Center of New York Inc | Stony Brook | New York | 11790 | — |
| Wake Research Associates Llc | Raleigh | North Carolina | 27612 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27104 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Kgl Skin Study Center | Broomall | Pennsylvania | 19008 | — |
| Dermatology Associates of Plymouth Meeting | Plymouth Meeting | Pennsylvania | 19462 | — |
| Palmetto Clinical Trial Services | Anderson | South Carolina | 29621 | — |
| International Clinical Research Tennessee Llc | Murfreesboro | Tennessee | 37130 | — |
| Innovative Dermatology | Plano | Texas | 75024 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| The Dermatology and Laser Center of San Antonio | San Antonio | Texas | 78229 | — |
| Clinical Research Partners Llc | Richmond | Virginia | 23226 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04530344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2025 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04530344 live on ClinicalTrials.gov.